800 heart patients tracked for bleeding risks and Pill-Taking habits
NCT ID NCT07458191
First seen Mar 17, 2026 · Last updated May 19, 2026 · Updated 10 times
Summary
This study watches 800 adults with nonvalvular atrial fibrillation who are starting the blood thinner apixaban for the first time. Researchers check how often serious or minor bleeding happens and how well patients stick to their medication over six months. The goal is to improve safe use of this common heart drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NONVALVULAR ATRIAL FIBRILLATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinic for diseases of the heart, blood vessels and rheumatism
RECRUITINGSarajevo, 71000, Bosnia and Herzegovina
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.